The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...

The US Food and Drug Administration (FDA) has approved Romvimza (vimseltinib), from Deciphera Pharmaceuticals, a kinase ...

OnePlus is hoping the OnePlus Watch 3 could get FDA approval for its new sleep apnea detection feature, bringing it one step ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

The results, published in The Lancet Diabetes and Endocrinology, showed that people in the sotagliflozin group had a 23 per cent reduction in the rate of heart attacks, strokes, and deaths from such ...

The approval was based on two late-stage trials that showed the drug led to significant elimination of migraine pain compared with a placebo. The FDA had declined to approve the drug in 2022 over ...

Grandfathered – Grandfathered refers to numerous older drugs approved before 1938 ... Drugs Available In the US Market in 201011 *Drugs against which FDA enforcement actions were taken.